# Braskem SA: financial statements, quarterly

BAK · NYSE · CIK 1071438 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bak.md) · [Financials](/companies/bak/financials.md) · [Filings](/companies/bak/filings.md) · [Insiders](/companies/bak/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bak/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [3.9](/filings/0001292814-19-003356.md) | [7.0](/filings/0001292814-19-003452.md) | [6.7](/filings/0001292814-20-002229.md) | [3.8](/filings/0001292814-21-002286.md) | [5.5](/filings/0001292814-22-001862.md) | [6.8](/filings/0001292814-23-001738.md) | [13.9](/filings/0001292814-24-001348.md) | [8.7](/filings/0001292814-25-001192.md) | [12.5](/filings/0001292814-25-001192.md) | [14.2](/filings/0001292814-25-001192.md) | [15.0](/filings/0001292814-25-001192.md) |
| Current assets | $bn | not reported | not reported | [15.9](/filings/0001292814-19-003356.md) | [17.4](/filings/0001292814-19-003452.md) | [21.0](/filings/0001292814-20-002229.md) | [23.4](/filings/0001292814-21-002286.md) | [34.2](/filings/0001292814-22-001862.md) | [39.3](/filings/0001292814-23-001738.md) | [34.5](/filings/0001292814-24-001348.md) | [37.4](/filings/0001292814-25-001192.md) | [37.0](/filings/0001292814-25-001192.md) |
| Total assets | $bn | not reported | not reported | [51.8](/filings/0001292814-19-003356.md) | [52.7](/filings/0001292814-19-003452.md) | [58.8](/filings/0001292814-20-002229.md) | [68.1](/filings/0001292814-21-002286.md) | [86.1](/filings/0001292814-22-001862.md) | [92.6](/filings/0001292814-23-001738.md) | [88.0](/filings/0001292814-24-001348.md) | [91.7](/filings/0001292814-25-001192.md) | [102](/filings/0001292814-25-001192.md) |
| Current liabilities | $bn | not reported | not reported | [22.9](/filings/0001292814-19-003356.md) | [18.6](/filings/0001292814-19-003452.md) | [22.8](/filings/0001292814-20-002229.md) | [16.2](/filings/0001292814-21-002286.md) | [28.4](/filings/0001292814-22-001862.md) | [25.2](/filings/0001292814-23-001738.md) | [24.2](/filings/0001292814-24-001348.md) | [24.5](/filings/0001292814-25-001192.md) | [28.3](/filings/0001292814-25-001192.md) |
| Total liabilities | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [4.2](/filings/0001292814-23-001738.md) | [3.0](/filings/0001292814-23-001738.md) | not reported | not reported |
| Shareholders' equity | $bn | [5.6](/filings/0001292814-19-003356.md) | [0.9](/filings/0001292814-19-003452.md) | [2.7](/filings/0001292814-19-003356.md) | [6.3](/filings/0001292814-19-003452.md) | [6.5](/filings/0001292814-20-002229.md) | [4.9](/filings/0001292814-21-002286.md) | [(2.2)](/filings/0001292814-22-001862.md) | [7.9](/filings/0001292814-23-001738.md) | [7.3](/filings/0001292814-24-001348.md) | [4.0](/filings/0001292814-25-001192.md) | [(4.8)](/filings/0001292814-25-001192.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 451,668,652 at 2025-12-31, from the cover of the [20-F filed 2026-04-20](/filings/0001292814-26-002427.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.